Yanhong Yao
Overview
Explore the profile of Yanhong Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao P, Zhong S, Liao J, Tao J, Yao Y, Song P, et al.
J Ethnopharmacol
. 2024 Nov;
339:119171.
PMID: 39613004
Ethnopharmacological Relevance: Caragana jubata (Pall.) Poir., a traditional Tibetan medicinal plant in China, is renowned in Tibetan medicine for its hypoglycemic properties and long-standing use in treating diabetes. Despite its...
2.
Tian C, Sheng Y, Yao Y, Zhao Y, Zhang N
Wei Sheng Yan Jiu
. 2024 Aug;
53(4):646-655.
PMID: 39155235
Objective: To develop a method which is used for rapid determination of 16 kinds of polycyclic aromatic hydrocarbons(PAHs) and 16 kinds of phthalates(PAEs) in tap water by stirring rod adsorption...
3.
Wang Z, Cheng S, Yao Y, Liu S, Liu Z, Liu N, et al.
Cancer Immunol Immunother
. 2024 Jul;
73(9):182.
PMID: 38967817
Background: The long-term survival benefit of immune checkpoint inhibitors (ICIs) in neoadjuvant and adjuvant settings is unclear for colorectal cancers (CRC) and gastric cancers (GC) with deficiency of mismatch repair...
4.
Chen M, Wang Z, Liu Z, Deng T, Wang X, Chang Z, et al.
JCO Precis Oncol
. 2023 Mar;
7:e2200463.
PMID: 36996375
Purpose: To investigate the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy versus anti-PD-1/PD-L1 monotherapy in advanced microsatellite instability (MSI)/mismatch repair-deficient (dMMR) gastrointestinal cancers. Methods: We retrospectively recruited patients with MSI/dMMR gastrointestinal...
5.
Yao Y, Yang X, Shen J, Zhao P
Pharmaceuticals (Basel)
. 2023 Jan;
16(1).
PMID: 36678522
GLUT4 is an important glucose transporter, which is closely related to insulin resistance and type 2 diabetes. In this study, we investigated the mechanism of Estradiol Dipropionate (EDP) on uptake...
6.
Liao J, Yang Z, Yao Y, Yang X, Shen J, Zhao P
Pharmaceuticals (Basel)
. 2022 Nov;
15(11).
PMID: 36355518
Glucose transporter 4 (GLUT4) is a membrane protein that regulates blood glucose balance and is closely related to type 2 diabetes. Andrographolide (AND) is a diterpene lactone extracted from herbal...
7.
Cheng H, Yao Y, Chen H, Zhao P, Kang X, Zhou X, et al.
Bioorg Chem
. 2022 Sep;
129:106160.
PMID: 36179442
Hyperhimatins A-P (1-16), sixteen new bicyclic polyprenylated acylphloroglucinols (BPAPs), were isolated and identified from Hypericum himalaicum. The planner structures of hyperhimatins A-P were confirmed via extensive NMR and careful HRESIMS...
8.
Yang Z, Yao Y, Sun M, Li G, Zhu J
Microorganisms
. 2022 Sep;
10(9).
PMID: 36144342
Feed input leads to a large amount of nitrogen-containing sediment accumulating in the substrate in the pond culture process, threatening the safety of aquaculture production. Planting lotus roots (Nelumbo nucifera...
9.
Yin W, Zhang H, Gu Y, Yi F, Li Q, Liu Y, et al.
Zhongguo Fei Ai Za Zhi
. 2022 Mar;
25(3):156-166.
PMID: 35340158
Background: Malignant pleural effusion is one of the common clinical manifestations of patients with lung adenocarcinoma. Patients with pleural effusion at the initial diagnosis of lung adenocarcinoma usually indicate poor...
10.
Li Q, Sun T, Zhang H, Liu W, Xiao Y, Sun H, et al.
Zhongguo Fei Ai Za Zhi
. 2022 Mar;
25(3):137-146.
PMID: 35340156
Background: The literature recommends that reduced dosage of CPT-11 should be applied in patients with UGT1A1 homozygous mutations, but the impact of UGT1A1 heterozygous mutations on the adverse reactions of...